Polyclonal anti-sera at 1:54 final dilution (number of assays) | Â | Infection intensity (number of oocysts per mosquito) | Infection prevalence (percent of mosquitoes with oocysts) | ||||
---|---|---|---|---|---|---|---|
 | Negative control | Pfs25 antibody | TBA-I | Negative control | Pfs25 antibody | TBA-P | |
MRA39 (n = 44) | Mean ± SD | 47.8 ± 32.9 | 8.4 ± 8.9 | 81.6 ± 12.9 | 93.8 ± 7.2 | 81.9 ± 16.5 | 12.9 ± 16.6 |
 | 95% CI | 38.1, 57.5 | 5.8, 11.1 | 77.7, 85.4 | 91.7, 96.0 | 77.0, 86.8 | 8.0, 17.8 |
 | Range | 3.7, 135.6 | 0.1, 47.0 | 36.5, 98.9 | 71.4, 100.0 | 8.3, 100.0 | −8.7, 89.6 |
MRA38 (n = 30) | Mean ± SD | 43.7 ± 25.8 | 1.3 ± 1.6 | 97.0 ± 3.9 | 94.6 ± 4.4 | 34.6 ± 27.1 | 63.5 ± 28.6 |
 | 95% CI | 34.5, 52.9 | 0.7, 1.8 | 95.6, 98.4 | 92.9, 96.3 | 24.9, 44.3 | 53.3, 73.7 |
 | Range | 7.1, 106.4 | 0.0, 4.8 | 87.4, 100.0 | 84.2, 100.0 | 0, 79.2 | 10.0, 100.0 |
Pooled data (n = 74) | Mean ± SD | 46.1 ± 30.1 |  |  | 94.2 ± 6.3 |  |  |
95% CI | 39.3, 52.5 | Â | Â | 92.7, 95.6 | Â | Â | |
Range | 3.7, 135.6 | Â | Â | 71.4, 100.0 | Â | Â |